Universal Cells
Ryan Davis, Ph.D. has accumulated diverse experience in the field of molecular and cellular biology. Ryan currently serves as an Associate Director at Universal Cells since May 2017 and has previously worked at Fred Hutch and Van Andel Institute. Ryan's research has focused on cancer cell metabolism, cancer signaling pathways, and anti-cancer small molecule compounds. Ryan holds a PhD in Molecular and Cellular Biology from the University of Washington, and a Bachelor of Science in Biology from Hope College.
Universal Cells
Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.